Brief: NanoCarrier decides to resume phase III clinical trial of NC-6004

Nano Holdings

20/04/2017 06:46

April 20 (Reuters) - NanoCarrier Co Ltd  4571.T  : 
     
    * Says it decides to resume phase III clinical trial of 
NC-6004      
     
    Source text in Japanese: https://goo.gl/rqOxuM 
    Further company coverage: 4571.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))